BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2211647)

  • 21. Functional assembly of intrinsic coagulation proteases on monocytes and platelets. Comparison between cofactor activities induced by thrombin and factor Xa.
    McGee MP; Li LC; Hensler M
    J Exp Med; 1992 Jul; 176(1):27-35. PubMed ID: 1613461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The binding of low molecular weight heparin to hemostatic enzymes.
    Jordan RE; Oosta GM; Gardner WT; Rosenberg RD
    J Biol Chem; 1980 Nov; 255(21):10073-80. PubMed ID: 6448845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface.
    Ahmad SS; Walsh PN
    Biochemistry; 2002 Sep; 41(37):11269-76. PubMed ID: 12220193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prothrombinase complex assembly. Kinetic mechanism of enzyme assembly on phospholipid vesicles.
    Krishnaswamy S; Jones KC; Mann KG
    J Biol Chem; 1988 Mar; 263(8):3823-34. PubMed ID: 3346225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Activation of factors IX and X by factor VIIa].
    Komiyama Y
    Rinsho Byori; 1992 Mar; Suppl 92():73-82. PubMed ID: 1583779
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
    Rosenberg RD
    Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localization of an antithrombin exosite that promotes rapid inhibition of factors Xa and IXa dependent on heparin activation of the serpin.
    Izaguirre G; Zhang W; Swanson R; Bedsted T; Olson ST
    J Biol Chem; 2003 Dec; 278(51):51433-40. PubMed ID: 14532267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zymogen factor IX potentiates factor IXa-catalyzed factor X activation.
    London FS; Walsh PN
    Biochemistry; 2000 Aug; 39(32):9850-8. PubMed ID: 10933803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The significance of circulating factor IXa in blood.
    Butenas S; Orfeo T; Gissel MT; Brummel KE; Mann KG
    J Biol Chem; 2004 May; 279(22):22875-82. PubMed ID: 15039440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of gamma-carboxyglutamic acid and epidermal growth factor-like modules of factor IX on factor X activation. Studies using proteolytic fragments of bovine factor IX.
    Astermark J; Hogg PJ; Björk I; Stenflo J
    J Biol Chem; 1992 Feb; 267(5):3249-56. PubMed ID: 1737781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of prothrombinase complex by plasma proteinase inhibitors.
    Ellis V; Scully MF; Kakkar VV
    Biochemistry; 1984 Nov; 23(24):5882-7. PubMed ID: 6335402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet procoagulant complex assembly in a tissue factor-initiated system.
    Monroe DM; Roberts HR; Hoffman M
    Br J Haematol; 1994 Oct; 88(2):364-71. PubMed ID: 7803283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by promoting the assembly of an intermediate heparin-antithrombin-factor Xa bridging complex. Demonstration by rapid kinetics studies.
    Rezaie AR; Olson ST
    Biochemistry; 2000 Oct; 39(39):12083-90. PubMed ID: 11009624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection of factor Xa from neutralization by the heparin-antithrombin complex.
    Teitel JM; Rosenberg RD
    J Clin Invest; 1983 May; 71(5):1383-91. PubMed ID: 6222069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex.
    Krishnaswamy S; Walker RK
    Biochemistry; 1997 Mar; 36(11):3319-30. PubMed ID: 9116010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p-Amidino esters as irreversible inhibitors of factors IXa and Xa and thrombin.
    Turner AD; Monroe DM; Roberts HR; Porter NA; Pizzo SV
    Biochemistry; 1986 Aug; 25(17):4929-35. PubMed ID: 3490273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies, with a luminogenic peptide substrate, on blood coagulation factor X/Xa produced by mouse peritoneal macrophages.
    Lindahl U; Kolset SO; Bøgwald J; Osterud B; Seljelid R
    Biochem J; 1982 Aug; 206(2):231-7. PubMed ID: 7150243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphatidylserine Regulation of Coagulation Proteins Factor IXa and Factor VIIIa.
    Majumder R
    J Membr Biol; 2022 Dec; 255(6):733-737. PubMed ID: 36098799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of acetylated factor X to prevent feedback activation of factor VIII during factor X activation: a tool for kinetic studies.
    Neuenschwander P; Jesty J
    Anal Biochem; 1990 Feb; 184(2):347-52. PubMed ID: 2109550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Directed glycosylation of human coagulation factor X at residue 333. Insight into factor Va-dependent prothrombin catalysis.
    Cook BC; Rudolph AE; Kurumbail RG; Porche-Sorbet R; Miletich JP
    J Biol Chem; 2000 Dec; 275(49):38774-9. PubMed ID: 10995746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.